Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Material control device for tableting clindamycin hydrochloride palmitate

A technology of clindamycin hydrochloride and palmitate, applied in the direction of presses, material forming presses, manufacturing tools, etc., can solve the problems of tablet weight deviation, difficult to control accurately, affect the use effect, etc., and achieve practical The effect of high performance, improved qualification rate and simple structure

Inactive Publication Date: 2017-03-22
江苏海阔生物医药有限公司
View PDF7 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The pharmaceutical tablet press is mainly used for tablet process research in the pharmaceutical industry; the pharmaceutical tablet press is an automatic continuous production equipment that compresses granules into round, special-shaped and tablets with text, symbols, and graphics with a diameter of no more than 13mm. Among them, the pharmaceutical tablet press mainly controls the amount of powdery medicine entering the middle die hole by controlling the size of the discharge port and the rotation speed of the middle die platform. This method is difficult to accurately control the weight of the drug entering the middle die hole , resulting in weight deviations in the pressed tablets, affecting the use effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Material control device for tableting clindamycin hydrochloride palmitate
  • Material control device for tableting clindamycin hydrochloride palmitate
  • Material control device for tableting clindamycin hydrochloride palmitate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0016] In order to make the object, technical solution and advantages of the present invention clearer, the present invention will be further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described here are only used to explain the present invention, not to limit the present invention.

[0017] Such as Figure 1-Figure 3 As shown, the material control device for clindamycin hydrochloride palmitate tableting according to the present invention includes: a feed pipe body 1 and a motor 2, and a feed hole 5 is arranged in the feed pipe body 1, so that A material retaining plate 4 is arranged in the feed hole 5, and the left end of the material retaining plate 4 is provided with a rotating shaft 3, and the material retaining plate 4 is fixedly connected with the rotating shaft 3 on the left side; the lower end of the motor 2 is provided with a The base 6, the upper end of the motor 2 is...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a material control device for tableting clindamycin hydrochloride palmitate. The material control device comprises a feed pipe body and a motor, wherein a feed hole is formed in the feed pipe body; a material baffle is arranged in the feed hole; a rotating shaft is arranged at the left end of the material baffle; a base is arranged at the lower end of the motor; a signal sensor is arranged at the upper end of the motor; a frequency modulation controller is arranged at the left upper end of the signal sensor; the frequency modulation controller and the signal sensor exchange signals through a connecting line; a control panel is arranged on a casing of the frequency modulation controller; and a power plug is arranged at the upper end of the frequency modulation controller. According to the material control device, the material baffle is arranged in the feed hole, the other end of the material baffle is fixedly connected with the rotating shaft of the motor, and the frequency modulation controller controls the time that the motor spends in rotating once and the rotation frequency of the motor to further control the weight of medicine powder which enters a middle mold hole through the feed hole; and the material control device has very high accuracy and improves yield of medicines.

Description

technical field [0001] The invention relates to the field of clindamycin hydrochloride palmitate tablet compression equipment, in particular to a material control device for clindamycin hydrochloride palmitate tablet compression. Background technique [0002] Clindamycin palmitate hydrochloride is a derivative of clindamycin, which has no antibacterial activity in vitro, and is hydrolyzed by esterase to form clindamycin in vivo to exert antibacterial activity. The mechanism of action of clindamycin is to inhibit the synthesis of bacterial proteins, mainly acting on the infection of Gram-positive cocci and anaerobic bacteria. The product has good antibacterial effect on Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus pyogenes, etc., and is moderately sensitive to Haemophilus influenzae and Neisseria gonorrhoeae. Some erythromycin-resistant Staphylococcus aureus and Staphylococcus epidermidis are still sensitive to this product. Thi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): B30B11/00B30B15/30
Inventor 苗玉武吕祖平刘永刚王丹丹刘言华
Owner 江苏海阔生物医药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products